For the quarter ending 2026-03-31, ZOMDF made $8,799K in revenue. -$4,591K in net income. Net profit margin of -52.18%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net revenue | 8,799 | 10,471 | 8,095 | 6,964 |
| Cost of revenue | 3,315 | 3,301 | 2,659 | 2,298 |
| Gross profit | 5,484 | 7,170 | 5,436 | 4,666 |
| General and administrative | 5,413 | 6,172 | 5,900 | 6,162 |
| Research and development | 1,154 | 1,643 | 1,784 | 1,886 |
| Selling and marketing | 3,817 | 4,519 | 4,358 | 4,653 |
| Impairment expense | - | 0 | - | - |
| Loss from operations | -4,900 | -5,164 | -6,606 | -8,035 |
| Interest income | 455 | 515 | 561 | 629 |
| Loss on disposal of assets | -15 | -25 | -36 | 1 |
| Other expense | -26 | -48 | -13 | -39 |
| Foreign exchange (loss) income | -9 | -22 | -46 | 58 |
| Loss before income taxes | -4,495 | -4,744 | -6,140 | -7,386 |
| Income tax expense (benefit) | 39 | -214 | -19 | 12 |
| Net loss | -4,534 | -4,530 | -6,121 | -7,398 |
| Unrealized loss, change in fair value of available-for-sale securities, net of tax | -43 | -8 | 34 | -10 |
| Change in foreign currency translation | -14 | -25 | -18 | 55 |
| Net loss and comprehensive loss | -4,591 | -4,563 | -6,105 | -7,353 |
| Basic EPS | 0 | -0.005 | -0.01 | -0.01 |
| Diluted EPS | 0 | -0.005 | -0.01 | -0.01 |
| Basic Average Shares | 979,949,668 | 979,949,668 | 979,949,668 | 979,949,668 |
| Diluted Average Shares | - | 979,949,668 | 979,949,668 | 979,949,668 |
Zomedica Corp. (ZOMDF)
Zomedica Corp. (ZOMDF)